By May 2026, public interest in SPARS had begun to wane. In late April the CDC had publicized an updated case fatality rate estimate, suggesting that SPARS was only fatal in 0.6 percent of cases in the United States.197 (Note: the 2020 COVID-19 case fatality rate was a mere 0.26 percent according to CDC).
